Treatment of SF126 and SF767 cells with 5-Aza-dC restored LRRC4 expression, which suggests that aberrant hypermethylation of the promoter is directly responsible for transcription inactivation of its expression in glioma cell lines. Here, LRRC4 is linked to central nervous system cancer.